Screening which avoids needle insertion into prostate gland also used to detect skin or breast cancer
AXA PPP healthcare has teamed up with screening service, Check4Cancer, to enhance its prostate cancer diagnosis pathway. Available to its individual, SME and large corporate members, the new approach avoids the invasive routine of taking small samples of tissues for analysis via needle insertion into the prostate gland through the wall of the rectum, which misses cancer 50% of the time and can often lead to infection. Prostate cancer is the most common cancer in men and, according to Prostate...
For ‘standing up to task’
‘Positive time to advertise insurance’
Online ceremony on 15 July
Insurer adds digital approach to allow its existing customers to place their policies in trust
Almost 1.2 million visits in a year